No Prescription |
 |
 | ||
|
Gestanin (Allyloestrenol) |
|
| ||
No Prescription » Birth Control » Gestanin (Allyloestrenol) Gestanin (Allyloestrenol) is a progestogen structurally related to progesterone that has been given in threatened and habitual abortion and to prevent premature labour. However with the exception of proven progesterone deficiency such use is no longer recommended. Buy Gestanin (Allyloestrenol) and other Birth Control products online at Medstore. Buy Online at Medstore - Click Here!
About Gestanin (Allyloestrenol): Product Type: Birth Control Brand name: Gestanin Generic name: Allyloestrenol Common uses This medicine is a progestogen structurally related to progesterone that has been given in threatened and habitual abortion and to prevent premature labour. However with the exception of proven progesterone deficiency such use is no longer recommended. Before using Some medicines or medical conditions may interact with this medicine. Inform your doctor or pharmacist of all prescription and over-the-counter medicine that you are taking. Do not start or stop any medicine without doctor or pharmacist approval. Contact your doctor or pharmacist if you have any questions or concerns about using this medicine. Directions Follow the directions for using this medicine provided by your doctor. Dosage: one tablet three times a day and maximum up to 4 tablets a day until symptoms improve. Cautions Check with your doctor if you have cardiac or renal dysfunction migraine epilepsy and asthma. Possible side effects Gastrointestinal complaints like nausea vomiting epigastric discomfort have been reported. If you take too much If overdose is suspected contact your local poison control center or emergency room immediately. Symptoms of overdose may include unusual drowsiness; rapid pulse; fainting; unusual muscle movement or rigidity of the face neck or limbs; seizures; and loss of consciousness. Additional information Do not share this medicine with others for whom it was not prescribed. Do not use this medicine for other health conditions. Keep this medicine out of the reach of children and pets. If using this medicine for an extended period of time obtain refills before your supply runs out. Drug interactions Drug interactions can result in unwanted side effects or prevent a medicine from doing its job. Some medicines or medical conditions may interact with this medicine. Inform your doctor or pharmacist of all prescription and over-the-counter medicine that you are taking Generic Gestanin (Allyloestrenol) Gestanin (Allyloestrenol) 5mg 120 pills 5mg 240 pills 5mg 60 pills 5mg 30 pills 5mg 90 pills Allyloestrenol Gestanin
View more Birth Control No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
